多巴胺疗法对波动性帕金森病患者睡眠质量的影响
Claudia Ledda1,2, Alberto Romagnolo1,2, Anna Covolo1,2
1Department of Neuroscience "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
Journal of neurology
|April 12, 2024
概括
多巴胺激动剂 (DA) 补充疗法可以改善晚期帕金森病 (PD) 患者的睡眠质量,这些患者症状波动. 这项研究发现,DA治疗与PD患者的睡眠障碍减少和更好的睡眠得分有关.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 运动障碍 运动障碍
背景情况:
- 睡眠障碍在帕金森病 (PD) 中很常见,严重影响患者的生活质量.
- 抗帕金森症药物的确切影响,特别是多巴胺基疗法,对晚期PD的睡眠质量仍然不清楚.
研究的目的:
- 为了研究睡眠功能障碍和多巴胺激素治疗之间的相关性,在一个大队伍的晚期PD患者.
- 为了确定多巴胺疗法是否会影响PD患者的睡眠质量和过度白天嗜睡 (EDS).
主要方法:
- 使用PD睡眠量表 (PDSS-2) 和爱普沃思睡眠量表 (ESS) 来评估281名晚期PD患者的睡眠质量和EDS.
- 采用二元逻辑回归和协差分析来评估多巴胺疗法 (包括剂量) 与睡眠参数之间的关联,并调整混因素.
主要成果:
- 66.2%的患者报告睡眠质量差,34.5%报告EDS.
- 多巴胺激动剂 (DA) 治疗与报告睡眠障碍的可能性降低两倍 (OR 0.498,p=0.035) 和PDSS-2分数降低有关.
- 较高的DA剂量与较低的PDSS-2总体得分相关,表明睡眠质量有所改善,尽管多巴胺疗法对EDS没有显著的影响.
结论:
- 多巴胺激动剂补充疗法对晚期,波动性帕金森病患者的睡眠质量产生积极影响.
- 这一发现表明,优化多巴胺疗法可能是改善特定PD患者睡眠的可行策略.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
REM Sleep Behavior Disorder
182
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
182
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43


